Vesicular system drug design has revitalised the efficacy of previous medications by effectively regulating and sustaining their therapeutic action. The objective this study is to evaluate feasibility utilizing pharmaceutical interventions target novel vesicular delivery systems. innovative medication administration minimize adverse effects while ensuring at a predetermined or reasonably consis...

Proniosomal drug delivery system is a stable provesicular in nanotechnology to overcome the drawbacks associated with other vesicular systems. These are water-soluble pro-vesicular carriers coated non-ionic surfactant which on hydration give niosomes. The encapsulated and shows systemic targeted of poorly soluble drugs increased bioavailability decreased side effects. Here we have covered chara...

Background/aim: Methotrexate (MTX) is a folic acid antagonist that widely used to treat osteosarcoma, leukemia, breast cancer, and autoimmune inflammatory diseases. The most important concerns with MTX are its poor solubility high toxicity, particularly in liver cells. To enhance minimize we encapsulated niosomes investigated hepatotoxicity mechanisms using genetic biomarkers. Materials methods...